A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of NV-101 in Dental Patients

NCT00154167 Phase 2 COMPLETED

The purpose of this study was: * to determine if NV-101 accelerates recovery from numbness compared to placebo * to evaluate safety of NV-101

Details

Lead sponsor	Novalar Pharmaceuticals, Inc.
Phase	Phase 2
Status	COMPLETED
Enrolment	122
Start date	2003-02
Completion	2003-06

Conditions

• Soft Tissue Anesthesia (Numbness)

Interventions

• NV-101 (phentolamine mesylate solution)

Countries

United States